Contributors
Alexander Abdurakhmanov(Tel Aviv University), Anna Dubaniewicz(Gdańsk Medical University), Howard Amital(Tel Aviv University), Marina Afanasyeva(Engelhardt Institute of Molecular Biology), Tomer Bashi(Tel Aviv University), Fabiola Atzeni(University of Messina), S. Bombardieri(University of Thessaly), Paul Albert(Cornell University), Alexandra Balbir‐Gurman(Technion – Israel Institute of Technology), Barbara Detrick(National Institutes of Health), Rute Alves(Centro Hospitalar do Porto), Elise E. Drouin, Vasiliki Kalliopi Bournia, Mahmoud Abu‐Shakra(Soroka Medical Center), Francesca Cainelli, Mariana Brandão(Centro Hospitalar do Porto), Melanie Deutsch(National and Kapodistrian University of Athens), José Paulo Andrade(Hospital de São João), Jozélio Freire de Carvalho, Coad Thomas Dow, E. Borella(Nuovo Ospedale San Giovanni di Dio), Fabrizio Conti(Policlinico Umberto I), Neta Brender-Gotlieb, María‐Teresa Arango(Tel Aviv University), Maurizio Benucci(Nuovo Ospedale San Giovanni di Dio), J. Correia(Cornell University), Isabel Tavares de Almeida(University of Lisbon), M. Domeneghetti(University of Thessaly), Alberto Batticciotto(Luigi Sacco Hospital), Andrea Di Domenicantonio, Vital Da Silva Domingues(Universidade do Porto), Alessandro Antonelli(University of Verona), Yolanda Braun‐Moscovici(Rambam Health Care Campus), Joab Chapman(Tel Aviv Sourasky Medical Center), A. Campar, David H. Dreyfus, Dimitrios P. Bogdanos(University of Thessaly), Antonio Puccetti(University of Genoa), A. Doria, Emily M. L. Chastain, Nancy Agmon‐Levin(Sheba Medical Center), R. Cervera(University of Thessaly), A. Della Rossa, Miri Blank(Tel Aviv University), Eytan Cohen(Tel Aviv University), Graziela Carvalheiras, Alison E. Baird(State University of New York), Samantha Bosis
Cited by 0
Related Papers
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Guidelines for the diagnosis and management of cystathionine beta‐synthase deficiency
|Journal of Inherited Metabolic Disease|2016|335
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
|European Heart Journal|2009|251
Phenotypes of organ involvement in sarcoidosis
|European Respiratory Journal|2018|245